These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25770923)

  • 1. Intertwined regulation of angiogenesis and immunity by myeloid cells.
    Rivera LB; Bergers G
    Trends Immunol; 2015 Apr; 36(4):240-9. PubMed ID: 25770923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of myeloid-derived suppressor cells.
    Condamine T; Mastio J; Gabrilovich DI
    J Leukoc Biol; 2015 Dec; 98(6):913-22. PubMed ID: 26337512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism.
    Yang F; Lee G; Fan Y
    Angiogenesis; 2024 Aug; 27(3):333-349. PubMed ID: 38580870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tumor metastasis by myeloid-derived suppressor cells.
    Condamine T; Ramachandran I; Youn JI; Gabrilovich DI
    Annu Rev Med; 2015; 66():97-110. PubMed ID: 25341012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
    Han EC; Lee J; Ryu SW; Choi C
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis.
    Méndez-Huergo SP; Blidner AG; Rabinovich GA
    Curr Opin Immunol; 2017 Apr; 45():8-15. PubMed ID: 28088061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?
    Mortara L; Benest AV; Bates DO; Noonan DM
    Curr Opin Pharmacol; 2017 Aug; 35():66-74. PubMed ID: 28623714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid cell trafficking and tumor angiogenesis.
    Schmid MC; Varner JA
    Cancer Lett; 2007 May; 250(1):1-8. PubMed ID: 17049723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenesis: making the tumor vulnerable to the immune system.
    Griffioen AW
    Cancer Immunol Immunother; 2008 Oct; 57(10):1553-8. PubMed ID: 18438662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
    Ye XZ; Yu SC; Bian XW
    J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.
    Marvel D; Gabrilovich DI
    J Clin Invest; 2015 Sep; 125(9):3356-64. PubMed ID: 26168215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
    Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immunity by antiangiogenic molecules in cancer.
    Terme M; Colussi O; Marcheteau E; Tanchot C; Tartour E; Taieb J
    Clin Dev Immunol; 2012; 2012():492920. PubMed ID: 23320019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis.
    Liang W; Ferrara N
    Cancer Immunol Res; 2016 Feb; 4(2):83-91. PubMed ID: 26839309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular galectins in tumor angiogenesis and cancer immunity.
    Thijssen VLJL
    Semin Immunopathol; 2024 Jul; 46(1-2):3. PubMed ID: 38990363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of myeloid cells in tumor angiogenesis and growth.
    Shojaei F; Zhong C; Wu X; Yu L; Ferrara N
    Trends Cell Biol; 2008 Aug; 18(8):372-8. PubMed ID: 18614368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape mechanisms from antiangiogenic therapy: an immune cell's perspective.
    Rivera L; Pandika M; Bergers G
    Adv Exp Med Biol; 2014; 772():83-99. PubMed ID: 24272355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.